Oct 1, 2021

The National Hemophilia Foundation is thrilled to announce the full implementation of its top legislative priority from 2020, The Hemophilia SNF Access Act.  This critical law will rectify a long-standing problem to improve access to skilled nursing facilities (SNFs) for Medicare beneficiaries with hemophilia and other bleeding disorders.  NHF has heard from many community members over the years about challenges accessing SNF facilities due to the way that Medicare reimburses bleeding disorders treatments.

Starting October 1, 2021, SNFs can bill separately for hemophilia and other inherited bleeding disorder treatments administered to Medicare beneficiaries needing care in a SNF. This change allows the SNF to either provide the bleeding disorder treatment(s) themselves or contract with a third-party such as an HTC or specialty pharmacy.

We will continue to update this page with more information about the implementation of the law and its implications for people with bleeding disorders and their families, HTCs, and others.  See here for additional details for different stakeholders:

For more information, or if you have any questions about the implementation of the law, please contact Marla Feinstein, mfeinstein@hemophilia.org

Stay connected with us! Subscribe to receive the latest news on treatments, clinical trials, advocacy issues, and NHF events.